Cenobamate

Common brands: Xcopri, Xcopri Maintenance Pack, Xcopri Titration Pack, Keppra Xr, Keppra

Top reporter: Sk Life Science, Inc.

Anti-epileptic Agent [EPC]Benzodiazepine [EPC]Mood Stabilizer [EPC]Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]
8,054
Total Reports
6,583
Serious Reports
179
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (2.22%)

Patient Demographics

Male
510
Female
609

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Cenobamate.

# Reaction Reports % of Total
1 SEIZURE 2,332
17.9%
2 PRODUCT DOSE OMISSION ISSUE 1,806
13.9%
3 FATIGUE 816
6.3%
4 SOMNOLENCE 796
6.1%
5 DIZZINESS 638
4.9%
6 OFF LABEL USE 615
4.7%
7 PRODUCT USE ISSUE 584
4.5%
8 FALL 425
3.3%
9 HEADACHE 373
2.9%
10 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 368
2.8%
11 DRUG INEFFECTIVE 337
2.6%
12 DRUG INTERACTION 334
2.6%
13 FEELING ABNORMAL 292
2.2%
14 GAIT DISTURBANCE 276
2.1%
15 BALANCE DISORDER 251
1.9%
16 MEMORY IMPAIRMENT 244
1.9%
17 NAUSEA 240
1.8%
18 RASH 213
1.6%
19 INSOMNIA 193
1.5%
20 GENERALISED TONIC-CLONIC SEIZURE 185
1.4%
21 VOMITING 185
1.4%
22 HOSPITALISATION 181
1.4%
23 DECREASED APPETITE 180
1.4%
24 ASTHENIA 170
1.3%
25 HYPERSOMNIA 166
1.3%
26 INCORRECT DOSE ADMINISTERED 165
1.3%
27 VISION BLURRED 164
1.3%
28 ANXIETY 163
1.3%
29 DEPRESSION 163
1.3%
30 DIPLOPIA 157
1.2%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.